Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-255,253
Closed -$1.06M 453
2025
Q2
$1.06M Sell
255,253
-266,707
-51% -$1.67M 0.03% 210
2025
Q1
$3.15M Sell
521,960
-86,564
-14% -$529K 0.07% 90
2024
Q4
$3.15M Buy
608,524
+177,855
+41% +$700K 0.08% 119
2024
Q3
$1.29M Buy
430,669
+330,280
+329% +$896K 0.03% 247
2024
Q2
$299K Buy
100,389
+54,157
+117% +$446K 0.01% 396
2024
Q1
$546K Sell
46,232
-15,571
-25% -$180K 0.02% 327
2023
Q4
$503K Sell
61,803
-94,101
-60% -$676K 0.02% 350
2023
Q3
$1.27M Buy
155,904
+5,000
+3% +$48K 0.02% 303
2023
Q2
$1.12M Buy
150,904
+103,677
+220% +$720K 0.02% 372
2023
Q1
$235K Hold
47,227
0.01% 508
2022
Q4
$228K Sell
47,227
-26,868
-36% -$132K ﹤0.01% 646
2022
Q3
$756K Sell
74,095
-44,820
-38% -$625K 0.01% 771
2022
Q2
$1.66M Buy
118,915
+65,582
+123% +$1.04M 0.02% 688
2022
Q1
$902K Buy
+53,333
New +$918K 0.01% 712
2018
Q1
Sell
-16,667
Closed -$614K 387
2017
Q4
$614K Buy
+16,667
New +$753K 0.01% 257

Other funds holding VSTM

UBS O'Connor's VSTM Position: Q3 2025 in Review

UBS O'Connor sold out of Verastem (VSTM) in Q3 2025, closing a stake of 255,253 shares — an estimated $1.06M sold.

UBS O'Connor first reported a position in VSTM in Q4 2017 and held it in 15 quarters. The position peaked at $3.15M in Q1 2025. 118 funds tracked by Wall St. Rank hold VSTM as of Q3 2025.

  • UBS O'Connor reported no remaining Verastem position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 255,253 Verastem shares in Q3 2025, an estimated $1.06M.
  • UBS O'Connor first reported a position in Verastem in Q4 2017 and held it in 15 quarters.
  • UBS O'Connor's Verastem position peaked at $3.15M in Q1 2025.
  • 118 funds tracked by Wall St. Rank held Verastem as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.